STOCK TITAN

PHARMACIELO LTD - $PCLOF STOCK NEWS

Welcome to our dedicated page for PHARMACIELO news (Ticker: $PCLOF), a resource for investors and traders seeking the latest updates and insights on PHARMACIELO stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PHARMACIELO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PHARMACIELO's position in the market.

Rhea-AI Summary
PharmaCielo (TSXV: PCLO) (OTCQX: PCLOF) and Ease Labs Pharma have secured a significant contract to supply 1.871 tons of pharma-grade CBD to the State of São Paulo, Brazil, under a new Public-Health Distribution Program. The product, 'Cannabidiol Ease Labs 100mg/ml,' is based on PharmaCielo's active pharmaceutical ingredient, marking a major milestone for both companies in the cannabinoid-based drug market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.09%
Tags
none
-
Rhea-AI Summary
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) benefits from the Colombian Ministries' decision to extend the timeframe for selling THC products, allowing producers 48 months instead of the original 24. This resolution supports PharmaCielo's position as Colombia's largest cannabis producer, with over 2.0 tonnes of THC extract in inventory for international sales growth. The company also plans to issue 2,079,152 common shares to settle a $457,415 debt, subject to TSXV approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.62%
Tags
none
-
Rhea-AI Summary
Benuvia Operations, LLC (Benuvia) and PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) announced a strategic partnership to produce cGMP pharmaceutical-grade Active Pharmaceutical Ingredients (APIs) for the global market. The partnership aims to deliver high-quality, reliable medicinal cannabis products, produced under strict standards, and extends beyond manufacturing to offer innovative finished dose form services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
partnership
Rhea-AI Summary
PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) announced financial results for the third quarter ended September 30, 2023. The company reported a revenue of $352,000, an adjusted EBITDA loss of $1,370,000, and a net loss of $2,761,000. Chairman and CEO, Marc Lustig, highlighted the company's unique position in supplying large, sophisticated consumer and pharmaceutical product manufacturers with pharma-grade extracts and dried flower. PharmaCielo also raised $1.5 million under its non-brokered private placement of debenture offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.34%
Tags
-
Rhea-AI Summary
PharmaCielo closes tranche of non-brokered private placement, raising $3.3 million. Company also plans to issue shares to settle $500,000 debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.09%
Tags
none
-
Rhea-AI Summary
PharmaCielo announces Q2 2023 financial results with $160k in revenue and a net loss of $3.6 million. CEO expects progress in sales and finance teams to result in meaningful growth and cash flow. Overhead expenses reduced by 25%. Non-brokered private placement raises $3.28 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.19%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
PharmaCielo announces its first shipment of CBD Isolate to South Africa, expanding its presence in the African continent. The customer is a specialty biotechnology company that offers private label cannabinoid pharmaceutical products in advanced medical cannabis markets worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
none
PHARMACIELO LTD

OTC:PCLOF

PCLOF Rankings

PCLOF Stock Data

27.38M
154.92M
8.46%
5.09%
All Other Miscellaneous Crop Farming
Agriculture, Forestry, Fishing and Hunting
Link
United States of America
Toronto